Phytomedicine Drug Discovery

Periplogenin rewires cholesterol-dependent signaling and antitumor immunity by targeting PCSK9 in cholangiocarcinoma

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →